|
Model Number 500FA |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Bacterial Infection (1735); Endocarditis (1834); Fever (1858); Pseudoaneurysm (2605); Heart Block (4444)
|
Event Date 01/01/2017 |
Event Type
Injury
|
Event Description
|
Medtronic received information via literature regarding a 36-year-old male patient with atopic dermatitis who developed infective endocarditis (ie) due to staphylococcus aureus (s.Aureus) in 2017 and 2020.The patient underwent implant of ats open pivot aortic and mitral mechanical valves, in 2017 and 2020 respectively (unique device identifier numbers not provided).Post-operatively, the patient developed complete atrioventricular (av) block, requiring permanent pacemaker implantation (ppmi).In 2021, the patient presented to the hospital with a persistent high fever.Transthoracic echocardiography (tte) noted ¿a trembling aortic prosthetic valve,¿ computed tomography (ct) detected aortic pseudoaneurysms and blood cultures were again positive for s.Aureus, leading to a new ie diagnosis.The patient underwent surgery to remove the pacemaker leads and replace the mechanical valves with new open pivot aortic/mitral valves (unique device identifier numbers not provided).Intra-operatively, the aortic annulus was noted to be infected with pseudoaneurysms and pledgets sown into the site from the prior surgeries were also infected.The patient was placed on antibiotics, which were continued upon hospital discharge.Post-operative tte and one-year follow-up revealed no issues.No additional adverse patient effects or product performance issues were reported.
|
|
Manufacturer Narrative
|
Citation: yajima s.; et al.A novel patch-sparing technique for reconstruction of the aortomitral curtain.Eur j cardiothorac surg 2022; doi:10.1093/ejcts/ezac405.Pmid: (b)(6).Advance access publication 29 july 2022.Medtronic products referenced: ats open pivot (pma# p990046, product code: lwq).Earliest approved product used for product code and pma#.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|